Denham JW - Search Results

1

Gleason scoring: a comparison of classical and modified (international society of urological pathology) criteria using nadir PSA as a clinical end point.

Delahunt B, Lamb DS, Srigley JR, Murray JD, Wilcox C, Samaratunga H, Atkinson C, Spry NA, Joseph D, Denham JW. Delahunt B, et al. Among authors: denham jw. Pathology. 2010 Jun;42(4):339-43. doi: 10.3109/00313021003787924. Pathology. 2010. PMID: 20438406

2

Treatment and planning decisions in non-small cell carcinoma of the lung: an Australasian patterns of practice study.

Hamilton CS, Denham JW, Joseph DJ, Lamb DS, Spry NA, Gray AJ, Atkinson CH, Wynne CJ, Abdelaal A, Bydder PV, et al. Hamilton CS, et al. Among authors: denham jw. Clin Oncol (R Coll Radiol). 1992 May;4(3):141-7. doi: 10.1016/s0936-6555(05)81075-1. Clin Oncol (R Coll Radiol). 1992. PMID: 1375093

3

Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution study.

Denham JW, Hamilton CS, Christie D, O'Brien M, Bonaventura A, Stewart JF, Ackland SP, Lamb DS, Spry NA, Dady P, et al. Denham JW, et al. Int J Radiat Oncol Biol Phys. 1995 Jan 15;31(2):305-13. doi: 10.1016/0360-3016(94)E0065-R. Int J Radiat Oncol Biol Phys. 1995. PMID: 7836084 Clinical Trial.

4

Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG).

Denham JW, Burmeister BH, Lamb DS, Spry NA, Joseph DJ, Hamilton CS, Yeoh E, O'Brien P, Walker QJ. Denham JW, et al. Radiother Oncol. 1996 Jul;40(1):31-43. doi: 10.1016/0167-8140(96)01762-8. Radiother Oncol. 1996. PMID: 8844885 Clinical Trial.

5

Concurrent chemoradiation for oesophageal cancer: factors influencing myelotoxicity.

MacKean J, Burmeister BH, Lamb DS, Denham JW. MacKean J, et al. Among authors: denham jw. Australas Radiol. 1996 Nov;40(4):424-9. doi: 10.1111/j.1440-1673.1996.tb00440.x. Australas Radiol. 1996. PMID: 8996905 Clinical Trial.

6

Mucosal regeneration during radiotherapy. Trans Tasman Radiation Oncology Group (TROG).

Denham JW, Walker QJ, Lamb DS, Hamilton CS, O'Brien PC, Spry NA, Hindley A, Poulsen M, O'Brien M, Tripcony L. Denham JW, et al. Radiother Oncol. 1996 Nov;41(2):109-18. doi: 10.1016/s0167-8140(96)01830-0. Radiother Oncol. 1996. PMID: 9004352 Clinical Trial.

7

Long-term results of accelerated radiation treatment for advanced head and neck cancer.

Lamb DS, Denham JW, Morum PE, Gray AJ. Lamb DS, et al. Among authors: denham jw. Radiother Oncol. 1998 Oct;49(1):29-32. doi: 10.1016/s0167-8140(98)00078-4. Radiother Oncol. 1998. PMID: 9886694

8

Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapy.

Denham JW, Ackland SP, Burmeister B, Walpole E, Lamb DS, Dady P, Spry NA. Denham JW, et al. Eur J Cancer. 1999 Jun;35(6):921-7. doi: 10.1016/s0959-8049(99)00065-9. Eur J Cancer. 1999. PMID: 10533472

9

A quality assurance audit: phase III trial of maximal androgen deprivation in prostate cancer (TROG 96.01).

Steigler A, Mameghan H, Lamb D, Joseph D, Matthews J, Franklin I, Turner S, Spry N, Poulsen M, North J, Kovacev O, Denham J. Steigler A, et al. Australas Radiol. 2000 Feb;44(1):65-71. doi: 10.1046/j.1440-1673.2000.00774.x. Australas Radiol. 2000. PMID: 10761262 Clinical Trial.

10

Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer.

Lamb D, Atkinson C, Joseph D, O'Brien P, Ackland S, Bonaventura A, Dady P, Hamilton C, Spry N, Stewart J, Denham J. Lamb D, et al. Australas Radiol. 1999 May;43(2):220-6. doi: 10.1046/j.1440-1673.1999.00638.x. Australas Radiol. 1999. PMID: 10901906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page